SBC Medical Group Holdings Incorporated Increase (Decrease) in Other Operating Liabilities
SBC Medical Group Holdings Incorporated (SBC) reported Increase (Decrease) in Other Operating Liabilities of -$17.60 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $44.81K, a 376.06% increase year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$62.41K.
- SBC Medical Group Holdings Incorporated increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $104.11K.
- SBC Medical Group Holdings Incorporated increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$4.55K, a 224.09% decline year-over-year.
- SBC Medical Group Holdings Incorporated increase (decrease) in other operating liabilities for fiscal 2025 was $10.97K, a 72.72% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated increase (decrease) in other operating liabilities for fiscal 2024 was $40.22K, a 745.03% increase from fiscal 2023.
- SBC Medical Group Holdings Incorporated increase (decrease) in other operating liabilities for fiscal 2023 was $4.76K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $44.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$17.60K 10-Q · filed 2026-08-13 | $86.51K derived: sum of 3 quarters · filed 2026-08-13 | $81.96K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$62.41K 10-Q · filed 2026-05-14 | $41.70K derived: sum of 2 quarters · filed 2026-05-14 | $37.16K derived: sum of 3 quarters · filed 2026-05-14 | $46.57K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $104.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $99.56K derived: sum of 2 quarters · filed 2026-03-27 | $108.98K derived: sum of 3 quarters · filed 2026-08-13 | $10.97K 10-K · filed 2026-03-27 |
| 2025-09-30 | -$4.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $4.86K derived: sum of 2 quarters · filed 2026-08-13 | -$93.14K 10-Q · filed 2025-11-14 | -$134.22K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $9.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$88.59K 10-Q · filed 2026-08-13 | -$129.67K derived: sum of 3 quarters · filed 2026-08-13 | -$126.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$98.00K 10-Q · filed 2026-05-14 | -$139.08K derived: sum of 2 quarters · filed 2026-05-14 | -$135.41K derived: sum of 3 quarters · filed 2026-05-14 | -$60.82K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$41.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$37.41K derived: sum of 2 quarters · filed 2026-03-27 | $37.18K derived: sum of 3 quarters · filed 2026-03-27 | $40.22K 10-K · filed 2026-03-27 |
| 2024-09-30 | $3.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $78.26K derived: sum of 2 quarters · filed 2025-11-14 | $81.29K 10-Q · filed 2025-11-14 | $6.83K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $74.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $77.63K 10-Q · filed 2025-08-13 | $3.17K derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $3.03K 10-Q · filed 2025-05-15 | -$71.42K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$74.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $4.76K 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $79.22K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |